Lipid Nanocapsule-Based Gels for Enhancement of Transdermal Delivery of Ketorolac Tromethamine

Table 5

Area under the curve of inhibition time after administration of ketorolac tromethamine loaded in optimized nano lipid capsules from different gel vehicles after induction of inflammation in rat paws by Aerosil injection (results are mean ± SD).

Treatment groups	AUC2-24 (%.h)
LNC 2%	510.59±7.00
gel %2	488.59±4.86
LNC 0.5%	152.59±5.4
gel 0.5%	119.87±5.89
Vehicle	11.01±4.86
No treatment	0.00±0.00